Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INCORPORATED (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Recently, VRTX broke through the 20-day moving average, which suggests a short-term bullish trend. The 20-day simple moving average is a popular trading tool. It provides a look back at a stock's ...

Average portfolio weight of all funds dedicated to VRTX is 0.51%, an increase of 5.07%. Total shares owned by institutions increased in the last three months by 1.10% to 287,243K shares.

Yahoo Finance Executive Editor Brian Sozzi spoke with the Dell brothers on two separate occasions. In this special clip, we bring you side-by-side commentary on their visions and hopes for the ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The company’s shares closed yesterday at $472.80.

Back-to-school sales are ramping up this week and the new Dell XPS 13 Snapdragon X Elite Laptop is seeing its first price ...

Back-to-school season means upgrading your tech for better products that will help you into the school year. But devices like monitors, laptops, and PCs can be pricey. Luckily, Dell is having a ...

Yes, Dell offers a rewards program aptly called Dell Rewards. You can sign up for a free membership to start earning 3% back on purchases ... on the righthand side of the screen.

Yahoo Finance Executive Editor Brian Sozzi spoke with the Dell brothers on two separate occasions. In this special clip, we bring you side-by-side commentary on their visions and hopes for the future ...